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journal homepage: www.e- jmii .comCORRESPONDENCEEmpyema thoracis due to Nocardia
otitidiscaviarumDear Editor
We read with interest the article on pulmonary nocardiosis
in southern Taiwan by Chen et al.1 In their study, eight of
the 20 patients with pulmonary nocardiosis had pleural
effusion and three of these patients had empyema
thoraces. Among these three nocardial empyema cases, the
authors reported a 61-year-old man with diabetes mellitus
and chronic liver disease suffering from an acute course of
empyema caused by Nocardia otitidiscaviarum.1 N. otiti-
discaviarum is a rare pathogen among nocardial infections
and pulmonary nocardiosis.2,3 We herein present another
case of N. otitidiscaviarum empyema after a short course
of corticosteroid for inflammatory arthritis.
A 42-year-old man with alcoholic liver cirrhosis,
ChildeTurcotteePugh score B, presented with esophageal
varices bleeding initially. On the 8th day after admission, a
5-day course of corticosteroid with hydrocortisone (100 mg
intravenously every 12 hours; equivalent dose Z 50 mg
prednisolone/day) was prescribed for inflammatory arthritis
of bilateral knees. The dose of corticosteroid was then
tapered to 20-mg prednisolone daily. On the 15th day, fever
with shaking chills and purulent coughwere noted. The chest
X-ray revealed right lower lobe infiltrate, and within a day
the right pleural effusion developed rapidly. Results of the
pleural effusion study revealed the presence of exudate
(pleural effusion/serum protein, 4.0/7.2 g/dL; pleural fluid/
lactate dehydrogenase, 915/153 IU/L) with a cell count of
8653/mm3 and a predominance of polymorphic neutrophils
(polymorphic neutrophils/monocytes: 87%/13%). No micro-
organism was identified with Gram staining and acid-fast
staining of the pleural effusion. An antibiotic combination
of piperacillinetazobactam and vancomycin was used for
treatinghospital-acquired pneumonia. The clinical condition
deteriorated and the patient was intubated on the 8th day
after symptom onset. Because of a poor response to medical
therapy, video-assisted thoracoscopic surgery (VATS)http://dx.doi.org/10.1016/j.jmii.2014.05.004
1684-1182/Copyright ª 2014, Taiwan Society of Microbiology. Publishedecortication was performed on the 13th day after symptom
onset. Thirteen days after the operation, the patient was
dischargedwithoral ciprofloxacin; however, the rightpleural
effusionwas still noted before discharge. Pus formation from
the previous operation wound was noted 7 days after
discharge. Another chest X-ray was performed, which
revealed persistent right pleural effusion. A second VATS
decortication was performed and the pleural effusion cul-
ture grew Nocardia spp. Therefore, we changed the antibi-
otic regimen to meropenem, trimethoprimesulfamet
hoxazole (TMPeSMZ), and amikacin. After an 11-day com-
bination therapy, we continued another 5-month course of
the oral form of TMPeSMZ and the patient recovered un-
eventfully. There was no recurrence after 24 months of
follow up. This isolate was further identified as N. otiti-
discaviarum by 16S ribosomal RNA gene sequencing. The
details of this method were described previously.2
N. otitidiscaviarum is a rare species among nocardial
infections. In a multicenter study in Taiwan from 1998 to
2009, 5.7% of 138 clinical Nocardia species isolated were N.
otitidiscaviarum.3 In the United States, N. otitidiscaviarum
accounted for 4.44% of all Nocardia isolates (34/765) sub-
mitted to the Centers for Disease Control and Prevention
for antimicrobial susceptibility testing.4 To our knowledge,
only two other cases with N. otitidiscaviarum empyema
have been reported in the English literature (Table 1). The
mortality rate was 50% among these four cases. These two
cases had long-term use of corticosteroid for their under-
lying diseases. Our patient developed acute empyema after
a short course of corticosteroid for inflammatory arthritis.
The empyema did not resolve well after the first VATS and
relapsed under ciprofloxacin use. According to Lai and
Hsueh,2 among seven N. otitidiscaviarum isolates in
Taiwan, the resistance rates of amikacin, ciprofloxacin,
imipenem, and TMPeSMZ were 0%, 43%, 100%, and 0%,
respectively. This result was similar to that reported by
Uhde et al4 except for the susceptibility of TMPeSMZ. Thed by Elsevier Taiwan LLC. All rights reserved.
Table 1 Nocardia otitidiscaviarum empyema in the English literature
Author/
reference
Age
(y)
Sex Underlying
diseases
Steroid usea Clinical
course
Other site
involved
Treatment/antibiogramb Outcome
Present case 42 Male CLD Short term Acute None Meropenem, amikacin,
TMPeSMZ/ TMPeSMZ/NA
Survived
Chen et al1 61 Male CLD, DM Nil Acute None NA/NA Died
Yoshida et al5 69 Female Rheumatoid
vasculitis
Long term Acute None Imipenem, minocycline,
TMPeSMZ/ levofloxacin,
gentamycin, TMPeSMZ/LVFX, GM
Survived
Pelaez et al7 85 Female COPD Long term NA Brain
abscess
Imipenem, TMPeSMZ/ TMPeSMZ,
linezolid/IPM, LND, TMPeSMZ,
GM, AMK, CIP
Died
AMK Z amikacin; CIP Z ciprofloxacin; CLD Z chronic liver disease; COPD Z chronic obstructive pulmonary disease; DM Z diabetes
mellitus; GMZ gentamicin; IPMZ imipenem; LNDZ linezolid; LVFXZ levofloxacin; NAZ not mentioned; TMPeSMZZ trimethoprim-
sulfamethoxazole.
a Long term: steroid use for at least 2 weeks.
b Antibiograms are expressed as the antimicrobial susceptible profiles.
Correspondence 581resistance rate of TMPeSMZ is high (42%) in the United
States.4 This may explain why our case had breakthrough
empyema under oral ciprofloxacin use. The isolate reported
by Yoshida et al5 was also nonsusceptible to imipenem and
TMPeSMZ. An empirical multiple drug regimen is suggested
in transplant patients with critical condition, disseminated
nocardiosis, or central venous system involvement.6 At
first, three drugs in combination were used in our case due
to the rapid progression of empyema thoracis and the
critical condition of the patient. Once the patient became
stable, the antimicrobial therapy was shifted to mono-
therapy with TMPeSMZ.
We herein presented a patient who developed N. otiti-
discaviarum empyema thoracis after a short course of
corticosteroid for inflammatory arthritis. It is important to
emphasize that the variable antimicrobial resistance may
influence the treatment outcome. Species identification
and susceptibility testing may be helpful for choosing the
appropriate antimicrobial agent for patients with difficult-
to-treat nocardiosis.
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